• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Case study: Assessing the comparative safety of novel pulmonary embolism treatments

Case study: Assessing the comparative safety of novel pulmonary embolism treatments

by Truveta staff | Mar 11, 2024 | Research

Each year, approximately 900,000 patients in the US are affected by a pulmonary embolism (PE), a blood clot causing a blockage in one or more pulmonary arteries in the lungs. PE is a leading cause of in-hospital death in the US, and acute PE – a sudden blockage...
Beyond claims & hospital chargemaster data: Unlocking detailed EHR medical device data

Beyond claims & hospital chargemaster data: Unlocking detailed EHR medical device data

by Truveta staff | Aug 4, 2023 | Data, Technology

Medical devices play a key role in saving lives and improving patient outcomes on a global scale, yet most information about specific device safety and effectiveness is derived from pre-market clinical trials. Understanding medical device effectiveness in the...

Share this


Recent posts

  • Truveta leads a new era in cancer research with the most complete, representative, and timely real-world data on all cancers
  • Top 5 takeaways from Truveta Symposium 2025
  • Women’s health: Pain medication remains rare for women receiving IUDs

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Get started

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Interested in learning more?

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice